Wisconsin’s burgeoning biohealth sector continued to grow this summer as MilliporeSigma, a leading international life science business, broke ground on a new facility in Sheboygan and opened an expanded production facility in Verona.

The company’s projects are more evidence of the state’s strength in bioscience and pharmaceuticals.

MilliporeSigma, the U.S. and Canada life science business of Merck KGaA of Darmstadt, Germany, broke ground in July on a lateral flow membrane production facility in Sheboygan.

Click here to read the full article.